Processa Pharmaceuticals (PCSA) Stock Chart & Stock Price History $0.87 +0.03 (+4.04%) (As of 03:33 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals Stock Price Performance 5 Day Performance-7.62%1 Month Performance+1.27%3 Month Performance-34.90%6 Month Performance-55.79%Year-To-Date Performance-86.98%1 Year Performance-90.31% Receive PCSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now PCSA Stock Chart for Tuesday, December, 24, 2024 PCSA Chart by TradingView Processa Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/24/2024$0.84$0.87+4.04%$0.88$0.8239,572 shs$2.85 million12/23/2024$0.85$0.84-1.51%$0.91$0.81110,695 shs$2.74 million12/20/2024$0.94$0.85-9.84%$0.99$0.84191,585 shs$2.78 million12/19/2024$0.94$0.94+0.02%$0.97$0.94279,090 shs$3.08 million12/18/2024$1.01$0.94-6.67%$1.06$0.9482,375 shs$3.08 million12/17/2024$1.04$1.01-2.88%$1.07$0.99143,950 shs$3.30 million Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/16/2024$1.11$1.04-6.31%$1.10$1.01108,938 shs$3.40 million12/13/2024$1.25$1.11-11.20%$1.22$1.08156,111 shs$3.63 million12/12/2024$1.26$1.25-0.79%$1.33$1.15265,303 shs$4.08 million12/11/2024$1.33$1.26-5.26%$1.45$1.13914,618 shs$4.12 million12/10/2024$1.25$1.33+6.40%$1.50$1.2616.00 million shs$4.35 million12/09/2024$1.03$1.25+21.03%$1.25$0.99159,589 shs$4.08 million12/06/2024$1.03$1.03+0.76%$1.09$1.0321,225 shs$3.37 million12/05/2024$1.02$1.03+0.99%$1.03$0.9714,711 shs$3.35 million12/04/2024$1.07$1.02-5.14%$1.05$0.9611,724 shs$3.32 million12/03/2024$1.07$1.07+0.47%$1.08$1.0314,484 shs$3.50 million12/02/2024$1.16$1.07-7.87%$1.21$1.0675,370 shs$3.48 million11/29/2024$0.98$1.16+17.91%$1.17$1.0055,651 shs$3.78 million11/28/2024$0.98$0.98$1.02$0.9819,214 shs$3.20 million11/27/2024$1.02$0.98-3.91%$1.02$0.9819,214 shs$3.21 million11/26/2024$0.98$1.02+4.29%$1.10$0.9836,031 shs$3.34 million11/25/2024$0.86$0.98+13.71%$1.00$0.8637,496 shs$3.20 million Related Companies AIM ImmunoTech Stock Price Chart HCW Biologics Stock Price Chart TherapeuticsMD Stock Price Chart Marinus Pharmaceuticals Stock Price Chart PharmaCyte Biotech Stock Price Chart Sol-Gel Technologies Stock Price Chart ANEW Medical Stock Price Chart Aspira Women's Health Stock Price Chart Imunon Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Receive PCSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCSA Stock Alerts